Very early researchStudy completedNCT02900469What this trial is testingPresurgical Trial of Denosumab in Breast CancerWho this might be right forBreast Cancer NYU Langone Health 44
Testing effectiveness (Phase 2)Study completedNCT00490646What this trial is testingA Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer R-Pharm 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369What this trial is testingStudy of the Effects of Pembrolizumab in Patients With Advanced Solid TumorsWho this might be right forSquamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more University Health Network, Toronto 100
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT04032080What this trial is testingLY3023414 and Prexasertib in Metastatic Triple-negative Breast CancerWho this might be right forTriple Negative Breast Cancer Baylor Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT03430479What this trial is testingAnti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast CancerWho this might be right forBreast Cancer Kyoto Breast Cancer Research Network 32
Not applicableStudy completedNCT02057029What this trial is testingAssessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast CancerWho this might be right forBreast CancerEarly Stage Estrogen Receptor (ER) Positive Breast Cancer Yale University 96
Testing effectiveness (Phase 2)Study completedNCT00322517What this trial is testingStudy Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast CancerWho this might be right forBreast Neoplasms Pfizer 90
Large-scale testing (Phase 3)Study completedNCT03286842What this trial is testingTo Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.Who this might be right forHER2-ve Metastatic Breast CancerGermline BRCA1/2 MutationsSomatic BRCA1/2 Mutations AstraZeneca 256
Testing effectiveness (Phase 2)UnknownNCT04302441What this trial is testingEvaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant ChemotherapyWho this might be right forBreast Cancer Fudan University 550
Not applicableLooking for participantsNCT04480203What this trial is testingCoping After Breast Cancer - a Randomized Clinical Trial With Two Digital InterventionsWho this might be right forBreast Cancer PatientsHealth, Subjective Norwegian Institute of Public Health 390
Testing effectiveness (Phase 2)Study completedNCT00934856What this trial is testingTrastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 98
Large-scale testing (Phase 3)Active Not RecruitingNCT02032823What this trial is testingOlaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerWho this might be right forBreast Cancer AstraZeneca 1,836
Not applicableNot Yet RecruitingNCT07191405What this trial is testingClinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid TumorsWho this might be right forImmunotherapyChemotherapy Second Affiliated Hospital, School of Medicine, Zhejiang University 156
Early research (Phase 1)Looking for participantsNCT06623396What this trial is testingMesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric CancerWho this might be right forMesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT02536742What this trial is testingPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer ETOP IBCSG Partners Foundation 124
Testing effectiveness (Phase 2)Study completedNCT00003205What this trial is testingBryostatin 1 in Treating Patients With Stage IV Breast CancerWho this might be right forBreast Cancer University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT01431196What this trial is testingTrial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast CancerWho this might be right forStage II Breast CancerStage III Breast Cancer Clinica Universidad de Navarra, Universidad de Navarra 29
Not applicableEnded earlyNCT00740961What this trial is testingOlder Patients With Newly Diagnosed Breast Cancer or Colon CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+1 more Case Comprehensive Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00499122What this trial is testingNOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast CancerWho this might be right forBreast Cancer University of Miami 41